GlassScriptPhysician profile
Danielle Geneva Weekes
NPI 1902399108
$1,689.21
in general payments reported to CMS, 2019-2025
9 companies · $705 in 2025
The $705 reported for 2025 was more than what 88% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.24 · 2022: $527 · 2023: $214 · 2024: $213 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796 · Travel and Lodging: $268 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.33 |
| Travel and Lodging | $268.23 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $704.96 | 2025 | Avenir, Oxford, Oxford Partial Knee |
| Novo Nordisk INC | $576.99 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Pacira Pharmaceuticals Incorporated | $153.40 | 2024 | Iovera, Zilretta, Exparel |
| Currax Pharmaceuticals LLC | $79.32 | 2021-2022 | |
| Edwards Lifesciences Corporation | $59.72 | 2024 | Hemosphere |
| Bausch Health US, LLC | $54.52 | 2022 | |
| Idorsia Pharmaceuticals US INC | $22.75 | 2023 | Quviviq |
| Lilly USA, LLC | $21.04 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Weekes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.